Individuals Stopping Slimming Medications Gain Back Weight Four Times Faster Compared to Those on Conventional Diets

Fresh analysis indicates that people who discontinue new slimming jabs like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise plans.

Findings released in a prominent health publication demonstrates that while obese people frequently drop about a fifth of their body weight while using the jabs, the weight returns at an average rate of 0.8 kg per month after stopping.

"Users purchasing these drugs should be cognizant of the danger of quick weight regain when the therapy is stopped," stated expert Dr. Susan Jebb.

Such speed of regain implies a return to starting weight in about one and a half years.

Comparing Therapies

The research, which examined 37 of studies involving over 9,000 of participants, compared the effects of GLP-1 agonists with other pills.

The team point out that individuals who lose weight through lifestyle changes alone typically experience a slower weight regain—around 100 grams monthly—after stopping.

Understanding the Rapid Regain

Nutrition scientists suggest the mechanism of the jabs is key to understanding the heightened rebound.

The injections imitate a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its endogenous hormone, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Stopping of this medication means hunger is unsuppressed, making overeating far more likely."

An Ongoing Issue?

The NHS suggest the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Professionals argue that, considering the high risk of relapse, the treatment might need to be life-long.

This view is reinforced by pharmaceutical companies, who note that the results "underscore the persistent character of excess weight," similar to managing conditions like high blood pressure.

User Accounts

Individuals who have discontinued the jabs report a powerful resurgence of hunger.

"It felt as if something that goes on and you're instantly ravenous," described a patient.

The struggle is compounded if users have not established permanent dietary or behavioural modifications during treatment.

Widespread Interest

Figures suggest that millions of people in the UK have used these injections in the last 12 months, with demand continuing to grow.

• Adoption is greater among females compared to men.
• The middle-aged age group shows the greatest usage rates.
• Many obtain the medications through private prescriptions rather than the NHS.

In conclusion, experts stress that while these medications are powerful agents for shedding pounds, they are not a standalone cure and long-term success likely depends on integrated lifestyle management.